Gary S. Gillheeney is CEO & President at Organogenesis Holdings Inc. (ORGO). They have made 11 open-market trades across 1 company since 2021, most recently 2026-02-18.
CIK 0001757373
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORGO | 4,323,398 | $4.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORGO | SELL | 2024-12-13 | 2024-12-16 | $3.37 | $393K | -10.4% | -9.3% | +39.6% |
| ORGO | SELL | 2024-12-10 | 2024-12-12 | $3.62 | $1.7M | -9.1% | -14.3% | +50.3% |
| ORGO | SELL | 2024-12-06 | 2024-12-09 | $3.56 | $423K | -11.1% | -10.6% | +46.6% |
| ORGO | SELL | 2022-06-01 | 2022-06-03 | $5.55 | $2.7M | -7.0% | -5.2% | -34.2% |
| ORGO | SELL | 2022-05-26 | 2022-05-31 | $5.75 | $2.6M | -12.2% | -15.1% | -33.9% |
| ORGO | SELL | 2022-05-23 | 2022-05-25 | $5.66 | $1.9M | -4.2% | -13.0% | -29.2% |
| ORGO | SELL | 2022-05-18 | 2022-05-20 | $5.77 | $3.0M | -8.4% | -13.2% | -25.1% |
| ORGO | SELL | 2022-05-13 | 2022-05-17 | $6.02 | $3.8M | +5.5% | -12.4% | -14.0% |
| ORGO | SELL | 2021-07-16 | 2021-07-20 | $14.35 | $8.6M | +2.9% | -6.4% | -27.0% |
| ORGO | SELL | 2021-02-17 | 2021-02-18 | $13.28 | $2.8M | +21.0% | +59.2% | +26.4% |
| ORGO | SELL | 2021-02-11 | 2021-02-16 | $13.32 | $7.8M | +13.7% | +27.7% | +27.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.